Repeated annual influenza vaccination and vaccine effectiveness: review of evidence

References

• Burney LE. Influenza immunization: statement. Public Health Rep. 1960;75(10):944.
   PubMed Web of Science ®Google Scholar
• Langmuir AD, Henderson DA, Serfling RE. The epidemiological basis for the control of influenza. Am J Public Health Nations Health. 1964;54:563–571.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Gilbert M, Tweed SA, et al. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004–2005. Can Commun Dis Rep. 2005;31(Sep. 18):181–192.
   PubMedGoogle Scholar
• Skowronski DM, Janjua NZ, De Serres G, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010–2011 season. Clin Infect Dis. 2012;55(3):332–342.
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis. 2013;56(10):1363–1369.
   PubMed Web of Science ®Google Scholar
• Hoskins TW, Davies JR, Allchin A, et al. Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain. Lancet. 1973;2(7821):116–120.
   PubMed Web of Science ®Google Scholar
• Hoskins TW, Davies JR, Smith AJ, et al. Influenza at Christ’s Hospital: March, 1974. Lancet. 1976;1(7951):105–108.
   PubMed Web of Science ®Google Scholar
• Hoskins TW, Davies JR, Smith AJ, et al. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ’s Hospital. Lancet. 1979;1(8106):33–35.
   PubMed Web of Science ®Google Scholar
• Keitel WA, Cate TR, Couch RB, et al. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine. 1997;15(10):1114–1122.
   PubMed Web of Science ®Google Scholar
• Eaton MD, Martin WP. An analysis of serological reactions after vaccination and infection with the virus of influenza A. Am J Epidemiol. 1942;36:255–263.
   Google Scholar
• McDonald JC, Andrews BE. Diagnostic methods in an influenza vaccine trial. Br Med J. 1955;2(4950):1232–1235.
   PubMed Web of Science ®Google Scholar
• Smith DJ, Forrest S, Ackley DH, et al. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci U S A. 1999;96(24):14001–14006.
   PubMed Web of Science ®Google Scholar
• Zimmerman RK, Nowalk MP, Chung J, et al. 2014–2015 influenza vaccine effectiveness in the United States by vaccine type. Clin Infect Dis. 2016;63(12):1564–1573.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• Fu C, Xu J, Lin J, et al. Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012–2013 case-control evaluation of influenza vaccine effectiveness. Vaccine. 2015;33(25):2917–2921.
   PubMed Web of Science ®Google Scholar
• Gaglani M, Pruszynski J, Murthy K, et al. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013–2014 in the United States. J Infect Dis. 2016;213(10):1546–1556.
   PubMed Web of Science ®Google Scholar
• McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type. J Infect Dis. 2015;211(10):1529–1540.
   PubMed Web of Science ®Google Scholar
• Jimenez-Jorge S, Savulescu C, Pozo F, et al. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine. 2012;30(24):3595–3602.
   PubMed Web of Science ®Google Scholar
• Martinez-Baz I, Martinez-Artola V, Reina G, et al. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case-control study. BMC Public Health. 2013;13:191.
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in households with children during the 2012–2013 season: assessments of prior vaccination and serologic susceptibility. J Infect Dis. 2015;211(10):1519–1528.
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Petrie JG, Malosh RE, et al. Substantial influenza vaccine effectiveness in households with children during the 2013–2014 influenza season, when 2009 pandemic influenza A(H1N1) virus predominated. J Infect Dis. 2016;213(8):1229–1236.
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014;58(3):319–327.
   PubMed Web of Science ®Google Scholar
• Pebody RG, Andrews N, Fleming DM, et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiol Infect. 2013;141(3):620–630.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Janjua NZ, De Serres G, et al. Low 2012–13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. Plos One. 2014;9(3):e92153.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Janjua NZ, Sabaiduc S, et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011–2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis. 2014;210(1):126–137.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Chambers C, Sabaiduc S, et al. Integrated sentinel surveillance linking genetic, antigenic and epidemiologic monitoring of influenza vaccine-virus relatedness and effectiveness, 2013-14 season. J Infect Dis. 2015;212:726–739.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Chambers C, Sabaiduc S, et al. A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season. Clin Infect Dis. 2016;63(1):21–32.
   PubMed Web of Science ®Google Scholar
• Syrjanen RK, Jokinen J, Ziegler T, et al. Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009–2010 and 2010–2011 in Finland. Plos One. 2014;9(9):e108538.
   PubMed Web of Science ®Google Scholar
• Valenciano M, Kissling E, Reuss A, et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. Euro Surveill. 2016;21(7).
   Google Scholar
• Rondy M, Launay O, Puig-Barberà J, et al. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Eurosurveillance. 2015;20(2):21011.
   Web of Science ®Google Scholar
• Flannery B, Zimmerman RK, Gubareva LV, et al. Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015. J Infect Dis. 2016;214(7):1010–1019.
   PubMed Web of Science ®Google Scholar
• McLean HQ, Thompson MG, Sundaram ME, et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis. 2014;59(10):1375–1385.
   PubMed Web of Science ®Google Scholar
• Belongia EA, Kieke BA, Donahue JG, et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine. 2011;29(38):6558–6563.
   PubMed Web of Science ®Google Scholar
• Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004–2005 season to the 2006–2007 season. J Infect Dis. 2009;199(2):159–167.
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis. 2012;55(7):951–959.
   PubMed Web of Science ®Google Scholar
• Irving SA, Donahue JG, Shay DK, et al. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine. 2009;27(47):6546–6549.
   PubMed Web of Science ®Google Scholar
• Castilla J, Navascués A, Fernández-Alonso M, et al. Effectiveness of subunit influenza vaccination in the 2014–2015 season and residual effect of split vaccination in previous seasons. Vaccine. 2016;34(11):1350–1357.
   PubMed Web of Science ®Google Scholar
• Petrie JG, Ohmit SE, Johnson E, et al. Persistence of antibodies to influenza hemagglutinin and neuraminidase following one or two years of influenza vaccination. J Infect Dis. 2015;212(12):1914–1922.
   PubMed Web of Science ®Google Scholar
• Thompson MG, Naleway A, Fry AM, et al. Effects of repeated annual inactivated influenza vaccination among healthcare personnel on serum hemagglutinin inhibition antibody response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. Vaccine. 2016;34(7):981–988.
   PubMed Web of Science ®Google Scholar
• Mosterín Höpping A, McElhaney J, Fonville JM, et al. The confounded effects of age and exposure history in response to influenza vaccination. Vaccine. 2016;34(4):540–546.
   PubMed Web of Science ®Google Scholar
• Fonville JM, Wilks SH, James SL, et al. Antibody landscapes after influenza virus infection or vaccination. Science. 2014;346(6212):996–1000.
   PubMed Web of Science ®Google Scholar
• Davies JR, Grilli EA. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol Infect. 1989;102(2):325–333.
   PubMed Web of Science ®Google Scholar
• Miller MS, Gardner TJ, Krammer F, et al. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med. 2013;5(198):198ra07.
   Web of Science ®Google Scholar
• Morens DM, Burke DS, Halstead SB. The wages of original antigenic sin. Emerg Infect Dis. 2010;16(6):1023–1024.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Hottes TS, McElhaney JE, et al. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis. 2011;203(2):158–167.
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Janjua NZ, De Serres G, et al. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis. 2012;206(12):1852–1861.
   PubMed Web of Science ®Google Scholar
• O’Gorman WE, Huang H, Wei Y-L, et al. The split virus influenza vaccine rapidly activates immune cells through Fcγ receptors. Vaccine. 2014;32(45):5989–5997.
   PubMed Web of Science ®Google Scholar
• Halstead SB, Mahalingam S, Marovich MA, et al. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis. 2010;10(10):712–722.
   PubMed Web of Science ®Google Scholar
• Ndifon W. A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants. J R Soc Interface. 2015;12(112):20150627.
   PubMed Web of Science ®Google Scholar
• Bodewes R, Fraaij PLA, Kreijtz JHCM, et al. Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine. 2012;30(51):7407–7410.
   PubMed Web of Science ®Google Scholar
• Bodewes R, Kreijtz JH, Rimmelzwaan GF. Yearly influenza vaccinations: a double-edged sword? Lancet Infect Dis. 2009;9(12):784–788.
   PubMed Web of Science ®Google Scholar
• Bodewes R, Fraaij PLA, Geelhoed-Mieras MM, et al. Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children. J Virol. 2011;85(22):11995–12000.
   PubMed Web of Science ®Google Scholar
• Tsang JS. Utilizing population variation, vaccination, and systems biology to study human immunology. Trends Immunol. 2015;36(8):479–493.
   PubMed Web of Science ®Google Scholar
• Rizzo C, Bella A, Alfonsi V, et al. Influenza vaccine effectiveness in Italy: age, subtype-specific and vaccine type estimates 2014/15 season. Vaccine. 2016;34(27):3102–3108.
   PubMed Web of Science ®Google Scholar
• Garcia-Sastre A. Systems vaccinology informs influenza vaccine immunogenicity. Proc Natl Acad Sci U S A. 2016;113(7):1689–1691.
   PubMed Web of Science ®Google Scholar
• Kim JH, Davis WG, Sambhara S, et al. Strategies to alleviate original antigenic sin responses to influenza viruses. Proc Natl Acad Sci U S A. 2012;109(34):13751–13756.
   PubMed Web of Science ®Google Scholar
• Kim JH, Skountzou I, Compans R, et al. Original antigenic sin responses to influenza viruses. J Immunol. 2009;183(5):3294–3301.
   PubMed Web of Science ®Google Scholar
• Monto AS, Koopman JS, Longini IM Jr. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol. 1985;121(6):811–822.
   PubMed Web of Science ®Google Scholar
• Wheatley AK, Kent SJ. Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity. Expert Rev Vaccines. 2015;14(9):1227–1239.
   PubMed Web of Science ®Google Scholar
• Belongia EA, Simpson MD, King JP, et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016 Aug;16(8):942–951. doi: 10.1016/S1473-3099(16)00129-8. Epub 2016 Apr 6. PMID: 27061888.
   PubMed Web of Science ®Google Scholar